{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:31:33Z","timestamp":1649010693611},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00292-018-0441-y","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T08:18:40Z","timestamp":1524730720000},"page":"269-279","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Die neue S3-Leitlinie \u201ePr\u00e4vention des Zervixkarzinoms\u201c"],"prefix":"10.1007","volume":"39","author":[{"given":"D.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"441_CR1","volume-title":"Krebs in Deutschland 2009\/2010","author":"Robert Koch Institut","year":"2013","unstructured":"Robert Koch Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (2013) Krebs in Deutschland 2009\/2010"},{"key":"441_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00292-015-0120-1","volume":"37","author":"Marquardt","year":"2016","unstructured":"Marquardt, Stubbe, Broschewitz (2016) Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients. Pathologe 37:78\u201383. \n                    https:\/\/doi.org\/10.1007\/s00292-015-0120-1","journal-title":"Pathologe"},{"key":"441_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"Walboomers","year":"1999","unstructured":"Walboomers, Jacobs, Manos et al (1999) Human papillomavirus is a\u00a0necessary cause of invasive cervical cancer worldwide. J\u00a0Pathol 189:12\u201319. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199909)189:1\u300812::AID-PATH431\u30093.0.CO;2-F","journal-title":"J Pathol"},{"key":"441_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"Sanjose","year":"2010","unstructured":"Sanjose, Quint, Alemany et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a\u00a0retrospective cross-sectional worldwide study. Lancet Oncol 11:1048\u20131056. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(10)70230-8","journal-title":"Lancet Oncol"},{"key":"441_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","volume":"27","author":"Pirog","year":"2014","unstructured":"Pirog, Lloveras, Molijn et\u00a0al (2014) HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a\u00a0worldwide analysis of 760 cases. Mod Pathol 27:1559\u20131567. \n                    https:\/\/doi.org\/10.1038\/modpathol.2014.55","journal-title":"Mod. Pathol."},{"key":"441_CR6","first-page":"1","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012) Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1\u2013441","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"441_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/PAS.0b013e3182989ee2","volume":"37","author":"Herfs","year":"2013","unstructured":"Herfs, Parra-Herran, Howitt et al (2013) Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol 37:1311\u20131318. \n                    https:\/\/doi.org\/10.1097\/pas.0b013e3182989ee2","journal-title":"Am J Surg Pathol"},{"key":"441_CR8","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1073\/pnas.1202684109","volume":"109","author":"Herfs","year":"2012","unstructured":"Herfs, Yamamoto, Laury et\u00a0al (2012) A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA 109:10516\u201310521. \n                    https:\/\/doi.org\/10.1073\/pnas.1202684109","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"441_CR9","first-page":"2","volume":"11","author":"H Griesser","year":"2013","unstructured":"Griesser H, Marquardt K, Jordan B et\u00a0al (2013) Gyn\u00e4kologische Zytodiagnostik der Zervix. M\u00fcnchner Nomenklatur III. Frauenarzt 11:2\u20137","journal-title":"Frauenarzt"},{"key":"441_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","volume":"111","author":"Arbyn","year":"2008","unstructured":"Arbyn, Bergeron, Klinkhamer et al (2008) Liquid compared with conventional cervical cytology: a\u00a0systematic review and meta-analysis. Obstet Gynecol 111:167\u2013177. \n                    https:\/\/doi.org\/10.1097\/01.AOG.0000296488.85807.b3","journal-title":"Obstet Gynecol"},{"key":"441_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cncy.20140","volume":"119","author":"Schmidt","year":"2011","unstructured":"Schmidt, Bergeron, Denton et al (2011) p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology. Cancer Cytopathol 119:158\u2013166. \n                    https:\/\/doi.org\/10.1002\/cncy.20140","journal-title":"Cancer Cytopathol"},{"key":"441_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","volume":"105","author":"Ikenberg","year":"2013","unstructured":"Ikenberg, Bergeron, Schmidt et al (2013) Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study. J\u00a0Natl Cancer Inst 105:1550\u20131557. \n                    https:\/\/doi.org\/10.1093\/jnci\/djt235","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 3","key":"441_CR13","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","volume":"24","author":"Arbyn","year":"2006","unstructured":"Arbyn, Sasieni, Meijer et al (2006) Chapter\u00a09: clinical applications of HPV testing: a\u00a0summary of meta-analyses. Vaccine 24(Suppl 3):S78\u2013S89. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.117","journal-title":"Vaccine"},{"key":"441_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","volume":"136","author":"Darragh","year":"2012","unstructured":"Darragh, Colgan, Cox et al (2012) The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 136:1266\u20131297. \n                    https:\/\/doi.org\/10.5858\/arpa.LGT200570","journal-title":"Arch. Pathol. Lab. Med."},{"key":"441_CR15","volume-title":"LO Pr\u00e4vention des Zervixkarzinoms, Langversion 1.0. AWMF Registernummer: 015\/027OL","author":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe","year":"2017","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2017) LO Pr\u00e4vention des Zervixkarzinoms, Langversion 1.0. AWMF Registernummer: 015\/027OL"},{"key":"441_CR16","volume-title":"LO Pr\u00e4vention des Zervixkarzinoms, Leitlinienreport 1.0. AWMF Registernummer: 015\/027OL","author":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe","year":"2017","unstructured":"Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2017) LO Pr\u00e4vention des Zervixkarzinoms, Leitlinienreport 1.0. AWMF Registernummer: 015\/027OL"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-018-0441-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0441-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-018-0441-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T19:43:39Z","timestamp":1556221419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-018-0441-y"}},"subtitle":["Was ist wichtig f\u00fcr die Pathologie?"],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s00292-018-0441-y","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"26 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Schmidt war als Referent und Berater f\u00fcr die Firma Roche Tissue Diagnostics, Mannheim, t\u00e4tig und hat f\u00fcr diese T\u00e4tigkeit ein Beraterhonorar und Reisekostenunterst\u00fctzung erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}